Found: 2 articles

Article Edition
K.S. Grechukhina (1, 2), K.A. Vorontsova (1), T.M. Kuko (1), A.A. Prosvirnov (1), I.P. Ganshina (3), E.V. Lubennikova (3), I.V. Kolyadina (4, 5), L.G. Zhukova (1)
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
№7 / 2021
L.G. Zhukova, E.I. Chichikov, O.O. Gordeeva, D.A. Filonenko
PALBOCICLIB – NEW POSSIBILITIES OF THERAPY OF HORMON-POSITIVE HER2-NEGATIVE BREAST CANCER
№17 / 2017


Бионика Медиа